Search results
After Plunging -30.6% in 4 Weeks, Here's Why the Trend Might Reverse for Citius Pharmaceuticals,...
Zacks via Yahoo Finance· 1 year agoThe heavy selling pressure might have exhausted for Citius Pharmaceuticals, Inc. (CTXR) as it is...
Breakeven On The Horizon For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)
Simply Wall St. via Yahoo Finance· 8 months agoCitius Pharmaceuticals, Inc. (NASDAQ:CTXR) is possibly approaching a major achievement in its...
Citius Pharmaceuticals Inc (CTXR) Reports Q1 2024 Financials and Progress in Clinical Trials
GuruFocus.com via Yahoo Finance· 3 months agoLiquidity: Citius Pharmaceuticals Inc (NASDAQ:CTXR) reported $20.3 million in cash and cash equivalents as of December 31, 2023. Shares Outstanding: As of December 31, 2023, there were 158,966,576 ...